OBJECTIVE Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycystic ovary syndrome (PCOS) is characterized by androgen excess and irregular menses; androgens are drivers of increased metabolic risk in women with PCOS. Combined oral contraceptive pills (COCPs) are used in PCOS both for cycle regulation and to reduce the biologically active androgen fraction. We examined COCP use and risk of dysglycemia (prediabetes and type 2 diabetes) in women with PCOS. RESEARCH DESIGN AND METHODS Using a large U.K. primary care database (The Health Improvement Network [THIN]; 3.7 million patients from 787 practices), we carried out a retrospective population-based cohort study to determine dysglycemia risk (64,...
Polycystic ovarian syndrome is the most common endocrine disease of women in reproductive age frames...
Background & objectives: Polycystic ovary syndrome (PCOS) is an endocrinopathy warranting lifelong i...
BACKGROUND:Polycystic ovary syndrome (PCOS) has a prevalence of 8%-13%. Given the prevalence, divers...
OBJECTIVE: Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycy...
Abstract Background Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dysli...
[[abstract]]BACKGROUND: Polycystic ovary syndrome (PCOS) is a common disorder in women of reproducti...
Combined oral contraceptives (COC) are the most often used treatment modality for polycystic ovary s...
Abstract Background: Polycystic ovary syndrome (PCOS) has a prevalence of 8–13%. Given the prevalen...
Abstract Objective: The use of combined hormonal contraceptives (CHCs) worsens glucose tolerance, b...
Polycystic ovary syndrome is associated with dyslipidemia, dysglycemia, metabolic syndrome, and low-...
In the chronic treatment of polycystic ovary syndrome (PCOS), oral contraceptive pills (OCPs) are co...
Background: While combined oral contraceptives (COCs) are commonly used to treat polycystic ovary sy...
Polycystic ovary disorder (PCOS) is an endocrinopathy, a lasting individualized treatment through wa...
Background: Polycystic ovary syndrome (PCOS) has a prevalence of 8%-13%. Given the prevalence, diver...
Objective: To assess the risk of type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS...
Polycystic ovarian syndrome is the most common endocrine disease of women in reproductive age frames...
Background & objectives: Polycystic ovary syndrome (PCOS) is an endocrinopathy warranting lifelong i...
BACKGROUND:Polycystic ovary syndrome (PCOS) has a prevalence of 8%-13%. Given the prevalence, divers...
OBJECTIVE: Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycy...
Abstract Background Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dysli...
[[abstract]]BACKGROUND: Polycystic ovary syndrome (PCOS) is a common disorder in women of reproducti...
Combined oral contraceptives (COC) are the most often used treatment modality for polycystic ovary s...
Abstract Background: Polycystic ovary syndrome (PCOS) has a prevalence of 8–13%. Given the prevalen...
Abstract Objective: The use of combined hormonal contraceptives (CHCs) worsens glucose tolerance, b...
Polycystic ovary syndrome is associated with dyslipidemia, dysglycemia, metabolic syndrome, and low-...
In the chronic treatment of polycystic ovary syndrome (PCOS), oral contraceptive pills (OCPs) are co...
Background: While combined oral contraceptives (COCs) are commonly used to treat polycystic ovary sy...
Polycystic ovary disorder (PCOS) is an endocrinopathy, a lasting individualized treatment through wa...
Background: Polycystic ovary syndrome (PCOS) has a prevalence of 8%-13%. Given the prevalence, diver...
Objective: To assess the risk of type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS...
Polycystic ovarian syndrome is the most common endocrine disease of women in reproductive age frames...
Background & objectives: Polycystic ovary syndrome (PCOS) is an endocrinopathy warranting lifelong i...
BACKGROUND:Polycystic ovary syndrome (PCOS) has a prevalence of 8%-13%. Given the prevalence, divers...